Improving rehabilitation for veterans with serious mental illness
Official title: Enhancing Rehabilitation for Veterans With Serious Mental Illness Via Biomarker-Informed Cognitive Training
Run by VA Office of Research and Development · NCT06586164 · Data updated 2026-11-12
This study is testing a new computer program to help veterans with serious mental illnesses improve their thinking and daily life skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 83 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (San Diego, California) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | August 31, 2028 |
| Study ends | October 31, 2028 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT06586164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are veterans aged 18 to 75 with serious mental illnesses such as schizophrenia, schizoaffective disorder, or PTSD who are receiving treatment at VA Psychosocial Rehabilitation and Recovery Centers.
✕Probably not a fit
Patients with an estimated premorbid IQ below 70 or those with active substance use may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance therapeutic interventions for veterans suffering from serious mental illnesses (SMI) by introducing Targeted Cognitive Training (TCT). TCT is a computerized program designed to improve sensory information processing, which can lead to better cognitive and psychosocial functioning. The study will utilize EEG biomarkers to identify veterans who are most likely to benefit from this treatment, ensuring a tailored approach to rehabilitation. By focusing on veterans receiving care in VA Psychosocial Rehabilitation and Recovery Centers, the study seeks to address the cognitive impairments that significantly impact their daily lives.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cognitive functioning and quality of life for veterans with serious mental illnesses.
How similar studies have gone: Other studies have shown promise in using cognitive training approaches for similar populations, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veterans with SMI (e.g., schizophrenia, schizoaffective disorder, bipolar disorder, PTSD) being treated at PRRCs or co-located rehabilitative services. * Age 18 and 83 years. * Fluency in spoken and written English. * Ability to detect 1000 Hz tones binaurally at a 40-dB sound pressure level. * Ability to see with an acuity of 20/40 with both eyes tested together (corrected if applicable) by a standard printed Snellen eye chart reading card. Exclusion Criteria: * Estimated premorbid IQ below 70, as estimated via the WRAT-4 Reading subtest. * Active substance use other than cannabis within the last 30 days as determined by CPRS review, self- report, or positive urine drug screen (obtained as part of the screening process). * History of significant medical or neurological illness. * Inability to comprehend or provide informed consent.
Where it's running
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Gregory Light, PhD — VA San Diego Healthcare System, San Diego, CA
- Study coordinator: Joyce Sprock, BS
- Email: joyce.sprock@va.gov
- Phone: (858) 552-8585
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced care for early psychosis treatment
This study is testing whether a new, more supportive treatment for people experiencing their first episode of psychosis helps them stay engaged in their care better than standard treatment.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders
This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.
-
Valbenazine for adults with tardive dyskinesia who remain symptomatic on or after a VMAT2 inhibitor
This trial will test whether valbenazine reduces involuntary movements in adults with tardive dyskinesia who still have symptoms while taking or after stopping a VMAT2 inhibitor.
-
Enhancing Veteran-Clinician Collaboration in VA Care for Serious Mental Illness
This study tests a 10-session group program to help Veterans with serious mental illness collaborate better with their clinicians and care teams.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.